Literature DB >> 18042568

Information-theory based surrogate marker evaluation from several randomized clinical trials with continuous true and binary surrogate endpoints.

Assam Pryseley1, Abel Tilahun, Ariel Alonso, Geert Molenberghs.   

Abstract

BACKGROUND: Surrogate endpoints potentially reduce the duration and/or increase the amount of information available in a study, thereby diminishing patient burden and cost. They may also increase the effectiveness and reliability of research, through beneficial impact on noncompliance and missingness.
PURPOSE: In this article, we review the meta-analytic approach of Buyse et al. (2000) and its extension to mixed continuous and binary endpoints by Molenberghs Geys, and Buyse (2001).
METHODS: An information-theoretic alternative, based on Alonso and Molenberghs (2007a) is proposed. The method is evaluated using simulations and application to data from an ophthalmologic trial, with lines of vision lost at 6 months as candidate surrogate endpoints for lines of vision lost at 12 months. The method is implemented as an R function.
RESULTS: The information-theoretic approach is based on solid theory, easy to apply, and enjoys elegant properties. While the information-theoretic approach appears to be somewhat biased downwards, this is due to fact that it operates at explicitly observed outcomes, without the need for unobserved, latent scales. This is a desirable property. LIMITATIONS: While easy-to-use and implement, the theoretical foundation of the information-theory approach is more mathematical. It produces some bias for small to moderate trial/center sizes, and hence is recommended primarily for sufficiently large trials.
CONCLUSIONS: Since the meta-analytic framework can be computationally extremely expensive, the information-theoretic approach of Alonso and Molenberghs (2007a) is a viable alternative. For the ophthalmologic case study, the conclusion is that the lines of vision lost at sixth month do have some, but not overwhelming promise as a surrogate endpoint.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042568     DOI: 10.1177/1740774507084979

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  7 in total

1.  An information-theoretic approach to surrogate-marker evaluation with failure time endpoints.

Authors:  Assam Pryseley; Abel Tilahun; Ariel Alonso; Geert Molenberghs
Journal:  Lifetime Data Anal       Date:  2010-09-28       Impact factor: 1.588

2.  Center-Within-Trial Versus Trial-Level Evaluation of Surrogate Endpoints.

Authors:  Lindsay A Renfro; Qian Shi; Yuan Xue; Junlong Li; Hongwei Shang; Daniel J Sargent
Journal:  Comput Stat Data Anal       Date:  2014-10-01       Impact factor: 1.681

Review 3.  Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials.

Authors:  Qian Shi; Daniel J Sargent
Journal:  Int J Clin Oncol       Date:  2009-04-24       Impact factor: 3.402

4.  Evaluation of Surrogate Endpoints Using Information-Theoretic Measure of Association Based on Havrda and Charvat Entropy.

Authors:  María Del Carmen Pardo; Qian Zhao; Hua Jin; Ying Lu
Journal:  Mathematics (Basel)       Date:  2022-01-31

Review 5.  Informed decision-making: Statistical methodology for surrogacy evaluation and its role in licensing and reimbursement assessments.

Authors:  Christopher J Weir; Rod S Taylor
Journal:  Pharm Stat       Date:  2022-07       Impact factor: 1.234

Review 6.  Endoscopic ulcers as a surrogate marker of NSAID-induced mucosal damage.

Authors:  R Andrew Moore
Journal:  Arthritis Res Ther       Date:  2013-07-24       Impact factor: 5.156

7.  Evaluation of surrogacy in the multi-trial setting based on information theory: an extension to ordinal outcomes.

Authors:  Hannah Ensor; Christopher J Weir
Journal:  J Biopharm Stat       Date:  2019-12-30       Impact factor: 1.051

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.